WebCordis Corporation recently announced that it has received CE mark approval for the treatment of acute myocardial infarction (AMI) using the CYPHER® SELECT™ PLUS sirolimus-eluting coronary stent. CE marking means conformity to the applicable European Directive, and in the specific context of AMI permits the CYPHER stent to be placed on … http://www.mrisafety.com/TMDL_view.php?editid1=5531
Coronary stents: historical development, current status …
WebApr 19, 2010 · The CYPHER Select® Plus Sirolimus-eluting Coronary Stent (SES) is a balloon-expandable intracoronary 316L stainless steel stent with a coating that consists of a blend of Sirolimus and polymers. Sirolimus is a potent immunosuppressive agent which has been proven to prolong graft survival in many animal models of transplantation. WebTYPHOON (Trial to assess the use of the cYPHer sirolimus-eluting stent in acute myocardial infarction treated with ballOON angioplasty) randomized 712 patients with STEMI treated by primary PCI to receive either SES (n = 355) or bare-metal stents (BMS) (n = 357). The primary end point, target vessel failure at 1 year, was significantly lower in ... how many homeless people in brisbane
corm - Food and Drug Administration
WebCall (888) 351-1904 to speak with a personal injury attorney. The Cypher stent is coated with a thin layer of polymer, which contains a drug called sirolimus. The sirolimus works as it is slowly released in hopes of reducing the rate of re-blockage, and restenosis, or reclosure. The stent can either be a punctured tube or a flexible wire that ... WebThe sirolimus-eluting stent (CYPHER( trade mark )) is a metal stent coated with 140 micro g/cm(2) of sirolimus blended with synthetic polymers. After stent implantation, sirolimus … WebCYPHER(R) Stent before undergoing an MRI test. About the CYPHER(R) Stent Developed and manufactured by Cordis Corporation, the CYPHER(R) Stent is currently available in … how add page numbers in powerpoint